Each year on September 26th, the medical community observes Mesothelioma Awareness Day. This year, Mesothelioma Hub remembers Inez St. John.
In August, the Centers for Medicare & Medicaid Services (CMS) approved the use of CAR T-cell therapy in patients with two specific cancers.
Results of a recent Phase 3 clinical trial lead researchers to believe immunotherapy drug Ofev is ineffective. Here are the details.
Newly signed bill helps those exposed to hazardous materials including asbestos at NYCs World Trade Center site.
In March of this year, the Food and Drug Administration (FDA) released a report citing its concern over asbestos-contaminated cosmetics.
The latest treatment for mesothelioma patients combines the power of electric currents with platinum-based chemotherapy drugs.
An new Phase 1 clinical trial using chimeric antigen receptor (CAR) T-cell therapy to attack pleural mesothelioma tumors shows promise for cancer patients.
Once the law goes into effect, any individual caught selling, buying, or distributing products containing asbestos will face a $2,500 fine.
The International Symposium on Malignant Mesothelioma, held at the Hyatt Regency Hotel in Bethesda, Maryland, lasted for three days.
Inez St. John was diagnosed with indirect mesothelioma. Read more about her experience and what you need to know.